LGNYZ LIGAND PHARMACEUTICAL INC
- 0.015
- 0.000-0.83%
LIGAND PHARMACEUTICAL INC News
Form 144 | Ligand Pharmaceuticals(LGND.US) Officer Proposes to Sell 3.87 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Nov 12, $LIGAND PHARMACEUTICAL INC(LGNXZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNYZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNZZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNDZ.US)$、$Ligand
10-Q: Quarterly report
LIGAND PHARMACEUTICAL INC (LGNYZ.US) will release financial reports before the market opens on November 7th.
$LIGAND PHARMACEUTICAL INC (LGNYZ.US)$ will release its financial report before the market opens on November 7th. Investors are advised to pay attention. futubull reminder: 1. There is no strict rule for the accounting year division time of companies listed in Hong Kong and the United States. It is completely up to the enterprise to decide. Therefore, each financial report period can be used as the company's annual report deadline, and will not be based on the calendar year as the fiscal year. 2. Generally, the company will hold a financial report conference on the above-mentioned financial report release date or on a nearby date, where the company's management will discuss the latest quarterly financial data and operational situation.
10-Q: Q2 2024 Earnings Report
Form 144 | Ligand Pharmaceuticals(LGND.US) Officer Proposes to Sell 446.84K in Common Stocks
SEC FILLINGS DISCLOSED/ May 17, $Ligand Pharmaceuticals(LGND.US)$、$LIGAND PHARMACEUTICAL INC(LGNDZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNXZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNYZ.US)$、$LIGAND PHARMACEUTIC
Form 144 | Ligand Pharmaceuticals(LGND.US) Officer Proposes to Sell 194.71K in Common Stocks
SEC FILLINGS DISCLOSED/ May 16, $Ligand Pharmaceuticals(LGND.US)$、$LIGAND PHARMACEUTICAL INC(LGNDZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNXZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNYZ.US)$、$LIGAND PHARMACEUTIC
Form 144 | Ligand Pharmaceuticals(LGND.US) Officer Proposes to Sell 505.15K in Common Stocks
SEC FILLINGS DISCLOSED/ May 15, $Ligand Pharmaceuticals(LGND.US)$、$LIGAND PHARMACEUTICAL INC(LGNDZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNXZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNYZ.US)$、$LIGAND PHARMACEUTIC
Form 144(Amend) | Ligand Pharmaceuticals(LGND.US) Officer Proposes to Sell 290.83K in Common Stocks
SEC FILLINGS DISCLOSED/ May 15, $Ligand Pharmaceuticals(LGND.US)$、$LIGAND PHARMACEUTICAL INC(LGNDZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNXZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNYZ.US)$、$LIGAND PHARMACEUTIC
Form 144 | Ligand Pharmaceuticals(LGND.US) Officer Proposes to Sell 1.2 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 14, $Ligand Pharmaceuticals(LGND.US)$、$LIGAND PHARMACEUTICAL INC(LGNDZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNXZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNYZ.US)$、$LIGAND PHARMACEUTIC
Form 144 | Ligand Pharmaceuticals(LGND.US) Officer Proposes to Sell 434.5K in Common Stocks
SEC FILLINGS DISCLOSED/ May 13, $Ligand Pharmaceuticals(LGND.US)$、$LIGAND PHARMACEUTICAL INC(LGNDZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNXZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNYZ.US)$、$LIGAND PHARMACEUTIC
Form 144 | Ligand Pharmaceuticals(LGND.US) Officer Proposes to Sell 830.45K in Common Stocks
SEC FILLINGS DISCLOSED/ May 9, $Ligand Pharmaceuticals(LGND.US)$、$LIGAND PHARMACEUTICAL INC(LGNDZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNXZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNYZ.US)$、$LIGAND PHARMACEUTICA
10-Q: Q1 2024 Earnings Report
Ligand to Report First Quarter 2024 Financial Results on May 7, 2024
Ligand Pharmaceuticals Announces New Topiramate Injection Data Presented at 9th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures Conference
Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMI
Analysis
Price Target
No Data
No Data